RepliCel Life Sciences Inc. reported that effective September 1, 2015, Gemma Fetterley as VP Finance, is no longer with the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0428 USD | +4.99% | -.--% | -4.89% |
May. 17 | RepliCel Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 18 | RepliCel Life Sciences Inc. Announces Secured Loan Agreement | CI |
1st Jan change | Capi. | |
---|---|---|
-4.89% | 2.78M | |
+14.90% | 118B | |
+13.00% | 106B | |
-3.07% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-16.93% | 15.56B | |
+4.67% | 13.63B | |
+28.41% | 12.27B |
- Stock Market
- Equities
- REPCF Stock
- News RepliCel Life Sciences Inc.
- RepliCel Life Sciences Inc. Announces Departure of Gemma Fetterley as VP Finance, Effective September 1, 2015